Results 181 to 190 of about 116,122 (261)

The level and clinical significance of serum soluble M-type phospholipase A2 receptor in patients with primary membranous nephropathy. [PDF]

Ren Fail
Wang ZH, Gao YM, Deng ZL, Wang Y.
europepmc   +1 more source

Exogenous pyruvate is therapeutic against colitis by targeting cytosolic phospholipase A2. [PDF]

Genes Dis
Hasan S, Ghani N, Zhao X, Good J, Liu CJ.   +4 more
europepmc   +1 more source

Hypercoagulability and dyslipidemia in membranous nephropathy with anti-phospholipase A2 receptor antibodies. [PDF]

Ren Fail
Kitlinski M, Heleniak Z, Dębska-Ślizień A.   +2 more
europepmc   +1 more source

Phospholipase A2 group IVD mediates the transacylation of glycerophospholipids and acylglycerols. [PDF]

J Lipid Res
Breithofer J, Bulfon D, Fawzy N, Tischitz M, Zitta C, Hartig L, Grabner GF, Pirchheim A, Hackl H, Taschler U, Lass A, Tam-Amersdorfer C, Strobl H, Kratky D, Zimmermann R.   +14 more
europepmc   +1 more source

Phospholipase A2 (PLA2) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

The Role of Serum Albumin and Secretory Phospholipase A2 in Sepsis. [PDF]

Int J Mol Sci
Tsao FHC, Li Z, Amessoudji AW, Jawdat D, Sadat M, Arabi Y, Meyer KC.   +6 more
europepmc   +1 more source

Rituximab or cyclosporine in the treatment of membranous nephropathy [PDF]

, 2019
al., et, Li, Tingting
core   +1 more source

Phospholipase A₂ products influence the antiplatelet functions of synthetic high-density lipoproteins. [PDF]

J Lipid Res
Rodriguez A, Yu M, Gan J, Phoo MT, Rani A, Marsche G, Guo Y, Holinstat M, Schwendeman A.   +8 more
europepmc   +1 more source